INS and Hyperinsulinemia: Patients with obesity are generally known to exhibit low-grade inflammation and hyperinsulinemia (25), and our study similarly observed increased insulin secretion and higher levodopa uptake in Group B compared to Group A. The elevated levodopa uptake can be explained by enhanced activity of LAT1 in patients with obesity.